Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors

Biological Psychiatry
Michael KometerF X Vollenweider

Abstract

Serotonin (5-HT) 1A and 2A receptors have been associated with dysfunctional emotional processing biases in mood disorders. These receptors further predominantly mediate the subjective and behavioral effects of psilocybin and might be important for its recently suggested antidepressive effects. However, the effect of psilocybin on emotional processing biases and the specific contribution of 5-HT2A receptors across different emotional domains is unknown. In a randomized, double-blind study, 17 healthy human subjects received on 4 separate days placebo, psilocybin (215 μg/kg), the preferential 5-HT2A antagonist ketanserin (50 mg), or psilocybin plus ketanserin. Mood states were assessed by self-report ratings, and behavioral and event-related potential measurements were used to quantify facial emotional recognition and goal-directed behavior toward emotional cues. Psilocybin enhanced positive mood and attenuated recognition of negative facial expression. Furthermore, psilocybin increased goal-directed behavior toward positive compared with negative cues, facilitated positive but inhibited negative sequential emotional effects, and valence-dependently attenuated the P300 component. Ketanserin alone had no effects but blocked the p...Continue Reading

References

Feb 1, 1989·Electroencephalography and Clinical Neurophysiology·F PerrinJ F Echallier
Jun 1, 1988·Journal of Personality and Social Psychology·D WatsonA Tellegen
Nov 1, 1995·Neural Computation·A J Bell, T J Sejnowski
Jun 1, 1994·Journal of Personality Assessment·R A SteerW F Ranieri
Jan 5, 2000·Psychological Medicine·F C MurphyE S Paykel
Dec 2, 2000·Journal of Medicinal Chemistry·J B BlairD E Nichols
Mar 31, 2001·Journal of Child Psychology and Psychiatry, and Allied Disciplines·S Baron-CohenI Plumb
Jul 5, 2002·Neuropsychobiology·E Gouzoulis-MayfrankM Spitzer
Dec 24, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C J HarmerG M Goodwin
Mar 20, 2003·Behavioural Brain Research·Bríd Aine Nic DhonnchadhaMartine Hascoët
Jan 2, 2004·The American Journal of Psychiatry·Zubin BhagwagarCatherine J Harmer
Feb 6, 2004·Pharmacology & Therapeutics·David E Nichols
Dec 2, 2004·Emotion·Susan L Rossell, Anna C Nobre
Nov 3, 2005·The American Journal of Psychiatry·Kristine EricksonBarbara J Sahakian
Nov 5, 2005·Journal of Cognitive Neuroscience·Olivia L CarterFranz X Vollenweider
Mar 15, 2006·Trends in Cognitive Sciences·Ahmad R Hariri, Andrew Holmes
May 2, 2006·Journal of Affective Disorders·Ellen GoelevenErnst H W Koster
Jan 9, 2007·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Kurt P SchulzJeffrey M Halperin
Feb 15, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Franz X VollenweiderBoris B Quednow
Jun 19, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·John Polich
Oct 16, 2007·Behavioural Brain Research·Vanessa Nunes-de-SouzaAzair Canto-de-Souza
Nov 11, 2008·Biological Psychiatry·Oliver J Robinson, Barbara J Sahakian
Apr 14, 2009·Behavior Research Methods·Melissa L-H VõArthur M Jacobs
May 9, 2009·Biological Psychiatry·Elena AkimovaSiegfried Kasper
Jun 2, 2009·Biological Psychology·Jason W Krompinger, Robert F Simons
Jun 23, 2009·Biological Psychiatry·Jonathan P RoiserWayne C Drevets
Jul 25, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·K S Gomes, R L Nunes-De-Souza
Sep 16, 2009·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Susan Jennifer ThomasStuart John Johnstone
Jan 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Lakshmi N YathamThomas J Ruth
Jun 24, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rebecca ElliottIan M Anderson
Jul 28, 2010·Frontiers in Neuroscience·Paul R Albert, Brice Le François
Aug 19, 2010·Nature Reviews. Neuroscience·Franz X Vollenweider, Michael Kometer
Sep 8, 2010·Archives of General Psychiatry·Charles S GrobGeorge R Greer

❮ Previous
Next ❯

Citations

Apr 26, 2014·Journal of Cancer Research and Therapeutics·Varsha Dutta
Oct 8, 2013·Social Cognitive and Affective Neuroscience·Cédric M HysekMatthias E Liechti
Aug 24, 2013·The American Journal of Drug and Alcohol Abuse·Brittany Vasae Burdick, Bryon Adinoff
Feb 15, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Thomas PokornyFranz X Vollenweider
Feb 6, 2016·Psychological Medicine·R L Carhart-HarrisD J Nutt
Feb 5, 2016·Pharmacological Reviews·David E Nichols
Nov 7, 2015·BioMed Research International·Débora GonzálezMagí Farré
Jun 3, 2014·Biological Psychiatry·Rainer KraehenmannFranz X Vollenweider
Sep 21, 2015·Biological Psychiatry·Mark A Geyer
May 27, 2015·Human Brain Mapping·Alexander V LebedevRobin L Carhart-Harris
Mar 19, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Michael P Bogenschutz, Matthew W Johnson
Jun 20, 2015·Frontiers in Psychology·Arthur M JacobsMario Braun
Feb 27, 2016·Human Brain Mapping·Milan ScheideggerSimone Grimm
Apr 20, 2016·Proceedings of the National Academy of Sciences of the United States of America·Katrin H PrellerFranz X Vollenweider
Feb 1, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Fosco BernasconiFranz X Vollenweider
Jul 19, 2014·Behavioural Brain Research·Adam L Halberstadt
Oct 10, 2013·The International Journal of Neuropsychopharmacology·Cédric M HysekMatthias E Liechti
Dec 19, 2013·The International Journal of Neuropsychopharmacology·R L Carhart-HarrisD J Nutt
Jun 2, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Patrick C DolderMatthias E Liechti
Sep 30, 2016·Expert Review of Neurotherapeutics·Bas T H de VeenJudith R Homberg
Nov 5, 2016·Neuroscience and Biobehavioral Reviews·Rafael G Dos SantosJaime E C Hallak
Jul 24, 2014·Journal of Psychopharmacology·Yasmin SchmidMatthias E Liechti
Jan 15, 2015·Journal of Psychopharmacology·Michael P BogenschutzRick J Strassman
Dec 11, 2014·Journal of Psychopharmacology·Anthony S GabayMitul A Mehta
Feb 26, 2016·NeuroImage. Clinical·Rainer KraehenmannFranz X Vollenweider
Apr 26, 2016·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Rafael G Dos SantosJaime E C Hallak
Apr 27, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robin L Carhart-Harris, Guy M Goodwin
Jun 24, 2017·The International Journal of Neuropsychopharmacology·Thomas PokornyFranz X Vollenweider
May 10, 2017·Journal of Psychoactive Drugs·Kelan ThomasDan Lastra
Nov 24, 2017·Frontiers in Pharmacology·Rainer KraehenmannFranz X Vollenweider
Feb 7, 2019·PloS One·Vince Polito, Richard J Stevenson
Apr 28, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthias E Liechti
Apr 3, 2019·Reviews in the Neurosciences·Noemi Császár-NagyIstván Bókkon
Jun 22, 2019·Pharmacological Reviews·R L Carhart-Harris, K J Friston
Mar 24, 2018·Frontiers in Pharmacology·Link R Swanson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.